Modifiers may be only two characters long, but they can make or break a claim. In this episode of Revenue RX, we explore why modifiers are like adjectives, adding the context that completes the story behind a claim. Learn about JW and JZ, the latest 340B modifier changes, modifiers for routes of administration, ESA and ESRD billing, and common mistakes that can lead to denials, payment delays, and audit findings.

Takeaways

• Understand what modifiers are and why they provide essential context to HCPCS and CPT codes.
• Learn when to report JW and JZ for drugs.
• Discover why CMS requires discarded drug reporting.
• Understand the latest 340B modifier requirements, including JG, TB, and UD.
• Learn when to use JA and JB to identify the route of administration.
• Review ESA modifiers (EA, EB, and EC) and the AY modifier for ESRD-related billing.
• Recognize common modifier mistakes that can result in denials, audits, and payment recoupments.
• Understand why modifier requirements vary by payer and should always be verified.

Chapters

00:00 Introduction: Why Modifiers Matter
00:22 What Is a Modifier?
01:11 Reporting Drug Waste: JW and JZ
01:46 Choosing the Right Vial Size
02:46 Why CMS Requires JW and JZ
04:46 340B Modifiers: JG, TB, and UD
06:40 Routes of Administration: JA and JB
07:04 ESA Modifiers: EA, EB, and EC
07:25 ESRD Modifier: AY
08:03 Common Modifier Mistakes
08:41 Disclaimer

References

• CMS Medicare Program: Discarded Drugs and Biologicals (JW and JZ Modifier) Frequently Asked Questions
• CMS Billing and Coding: JW and JZ Modifier Billing Guidelines
• CMS Billing 340B Modifiers Under the Hospital Outpatient Prospective Payment System (OPPS) FAQ

Disclaimer

This podcast is intended for informational and educational purposes only. The views expressed are personal opinions and do not represent those of any employer or affiliated organization. This content does not constitute legal, financial, compliance, reimbursement, or clinical advice. Healthcare regulations, payer policies, and reimbursement requirements vary by organization and jurisdiction. Always consult your internal compliance, legal, finance, revenue cycle, and operational teams before implementing any strategy discussed in this episode.

Revenue codes are one of the foundational elements of hospital billing, yet they are often misunderstood. In this episode of Revenue RX, we discuss what revenue codes are, how they function on the UB-04 claim form, and why they play an important role in pharmacy reimbursement.

The episode walks through the four primary pharmacy revenue code ranges, 025X, 026X, 063X, and 089X, explaining what each category represents and how pharmacy billing has evolved as medications have become more specialized and complex.

You will also hear practical examples of the revenue codes most commonly used by health systems, how payer reimbursement can vary based on the revenue code selected, and common billing mistakes that pharmacy and revenue cycle teams should avoid to protect reimbursement.

Takeaways

• Learn what revenue codes are and how they categorize services on the UB-04 claim form.
• Learn why revenue code 0636 requires submission of both the HCPCS code and the NDC.
• Understand how pharmacy billing requirements have evolved as drug therapies have become more specialized.
• Explore the revenue codes most commonly used by health systems.
• Learn how payer reimbursement may vary depending on the revenue code billed.

Chapters

00:00 Understanding Revenue Codes

01:45 The 025X Pharmacy Revenue Codes

02:35 The 026X IV Therapy Revenue Codes

03:00 The 063X Detailed Drug Billing Codes

03:31 The New 089X Cell and Gene Therapy Codes

05:06 Common Revenue Codes Used by Health Systems

06:18 Revenue Codes, Payer Requirements, and Common Billing Mistakes

Disclaimer

This podcast is for informational and educational purposes only. The views shared are my own and do not represent any organization that I am affiliated with. This is not legal, financial, or reimbursement advice. You should consult with your internal experts before making any decisions.

What if the UB-04 claim form wasn't just a collection of boxes and billing codes, but an epic story?

In this episode of Revenue RX, we reimagine the institutional claim form as a journey through a medieval kingdom. The patient becomes the hero, the hospital becomes the storyteller, and the payer becomes the king deciding whether the story deserves a bag of gold. Along the way, we explore how every section of the UB-04 (CMS-1450) helps tell the complete reimbursement story, from patient demographics and Type of Bill to diagnosis codes, revenue codes, HCPCS, NDCs, prior authorization, and provider information.

Takeaways

• Learn the purpose and structure of the UB-04 (CMS-1450) institutional claim form.
• Understand how each form locator contributes to the reimbursement story.
• Discover why Type of Bill, diagnosis codes, revenue codes, HCPCS, NDCs, and authorization numbers are critical for payment.
• See how incomplete or inconsistent claim information can lead to denials and payment delays.
• Gain a memorable storytelling framework for explaining reimbursement concepts to pharmacy, finance, and revenue cycle teams.
• Understand why successful reimbursement depends on telling a complete, accurate, and medically necessary story.

Chapters

00:00 Introduction to the UB-04 Claim Form
01:57 Once Upon a Claim
03:38 Meet the Hero
04:47 The Plot Thickens
06:17 Hidden Clues
06:54 The Action Begins
09:38 The King Takes the Throne
10:38 The Royal Family Tree
11:45 The Villain Appears
12:46 The Final Battle
13:14 The Supporting Cast

Disclaimer

This podcast is intended for informational and educational purposes only. The views expressed are personal opinions and do not represent those of any employer or affiliated organization. This content does not constitute legal, financial, compliance, reimbursement, or clinical advice. Healthcare regulations, payer policies, and reimbursement requirements vary by organization and jurisdiction. Always consult your internal compliance, legal, finance, revenue cycle, and operational teams before implementing any strategy discussed in this episode.

Healthcare reimbursement has a language all its own. In this episode of Revenue RX, we break down the essential reimbursement terminology that drives healthcare finance and pharmacy revenue cycle management.

Whether you're new to revenue cycle or looking to strengthen your financial acumen, this episode provides a foundational understanding of the acronyms, coding structures, and payment concepts that influence how healthcare organizations get paid.

Takeaways

• Understand the difference between billed charges, allowed amounts, and contractual adjustments.
• Learn why net revenue is a more meaningful financial metric than gross revenue.
• Distinguish between claim rejections and denials and understand their operational impact.
• Learn how CARCs and RARCs explain payment outcomes and denial reasons.
• Understand the role of remittance advice in the reimbursement process.
• Review revenue codes and modifiers.
• Learn the difference between HCPCS and CPT coding systems and how they work together.
• Gain familiarity with common drug pricing terminology including ASP, WAC, AWP, GPO, and 340B.
• Explore Medicare payment methodologies including APCs and DRGs.
• Understand important Medicare coverage and billing concepts such as NCDs, LCDs, LCAs, MACs, and MUEs.

Chapters

00:00 Understanding Healthcare Reimbursement Language
00:56 Billed Charge
01:31 Allowed Amount
02:04 Contractual Adjustment
02:32 Gross Revenue & Net Revenue
03:01 Revenue Cycle
03:42 Denials vs Rejections
04:35 CARCs & RARCs
05:16 The Remittance Advice
05:36 Revenue Codes
05:59 Modifiers
06:35 HCPCS
07:21 CPT
07:53 NDC
08:06 Drug Pricing Terminology
08:36 APC
08:48 DRG
09:07 MAC
09:35 NCD
09:42 LCD
09:50 LCA
09:59 MUE
10:15 Learning the Language
10:55 Disclaimer

Disclaimer

This podcast is intended for informational and educational purposes only. The views expressed are personal opinions and do not represent those of any employer or affiliated organization. This content does not constitute legal, financial, compliance, reimbursement, or clinical advice. Healthcare regulations, payer policies, and reimbursement requirements vary by organization and jurisdiction. Always consult your internal compliance, legal, finance, revenue cycle, and operational teams before implementing any strategy discussed in this episode.

A practical walkthrough of the revenue cycle ecosystem and how each team contributes to moving care from access to payment. This episode explains the roles of managed care, preaccess, pharmacy, clinical teams, revenue integrity, IT, HIM, coding, patient financial services, finance, and compliance, and why pharmacy leaders need to understand the full process.

Takeaways

• Revenue cycle success depends on coordinated handoffs across many teams.
• Managed care sets the rules that shape coverage, authorization, and reimbursement.
• Pharmacy plays a key role early in the process through medication-related documentation, authorization, and operational coordination.
• Revenue integrity connects clinical care, charge capture, coding, billing, and compliance.
• Pharmacy leaders should build relationships across revenue cycle, finance, compliance, and operations.

Chapters

00:00 Understanding the Revenue Cycle Ecosystem
01:53 Managed Care: Setting the Rules of the Game
03:26 Preaccess Teams: The Front Line
04:45 Pharmacy: The First Handoff
05:46 Clinical: Delivering and Documenting Care
06:45 Revenue Integrity: The Connective Tissue
09:11 IT: Building the Track
09:42 HIM: Protecting the Medical Record
10:26 Coding: Translating Care Into Billable Data
11:15 Patient Financial Services: Turning Claims Into Cash
12:02 Finance: Measuring Financial Performance
12:40 Compliance: The Referee
13:19 The Dream Team
14:20 What Pharmacy Leaders Should Do
15:38 Disclaimer

Disclaimer

This podcast is intended for informational and educational purposes only. The views expressed are personal opinions and do not represent those of any employer or affiliated organization. This content does not constitute legal, financial, compliance, reimbursement, or clinical advice. Healthcare regulations, payer policies, and reimbursement requirements vary by organization and jurisdiction. Always consult your internal compliance, legal, finance, revenue cycle, and operational teams before implementing any strategy discussed in this episode.

The podcast explores the July 2026 HCPCS coding updates and their impact on pharmacy revenue cycle operations. It reviews new drug and biosimilar HCPCS codes, deleted and reinstated codes, CMS's continued approach to 505(b)(2) products, and newly established administration codes. The episode emphasizes the operational importance of timely code implementation, reimbursement readiness, and cross-functional coordination to prevent denials, underpayments, and revenue leakage following the July 1 go-live.

Takeaways

• Understanding the July 2026 HCPCS Coding Updates
• Preparing Revenue Cycle Operations for July 1 Go-Live
• Evaluating New Biosimilar Reimbursement Implications
• Understanding CMS 505(b)(2) Billing Methodology Changes
• Operationalizing New Drug Administration Codes
• Reducing Revenue Leakage Through Proactive Readiness Assessments

Chapters

00:00 CMS July 2026 Updates
01:38 New HCPCS Codes
03:14 Biosimilar Additions
04:38 Deleted and Reinstated Codes
05:57 Understanding 505(b)(2) Products
06:08 Impact of 505(b)(2) Products on Reimbursement
06:44 New M-Codes and Administration Billing
08:21 Are You Ready for Go-Live?
09:31 Disclaimer

References

Centers for Medicare & Medicaid Services. (2026). HCPCS quarterly update July 2026 coding decisions. U.S. Department of Health and Human Services. https://www.cms.gov/medicare/coding-billing/healthcare-common-procedure-system/quarterly-update

Centers for Medicare & Medicaid Services. (2026, April 8). MLN Matters MM14470: July 2026 HCPCS quarterly update. U.S. Department of Health and Human Services. https://www.cms.gov/files/document/mm-14470-vaccine-administration-national-fee-schedule-july-2026-quarterly-update.pdf

Disclaimer

This podcast is intended for informational and educational purposes only. The views expressed are personal opinions and do not represent those of any employer or affiliated organization. This content does not constitute legal, financial, compliance, reimbursement, or clinical advice. Healthcare regulations, payer policies, and reimbursement requirements vary by organization and jurisdiction. Always consult your internal compliance, legal, finance, revenue cycle, and operational teams before implementing any strategy discussed in this episode.

The podcast explores how pharmacy revenue cycle leaders can use the midpoint of the year to evaluate financial performance, identify reimbursement risks, and strengthen operational processes before entering the second half of the year. The episode walks through five critical assessments that can help organizations improve reimbursement integrity, reduce revenue leakage, and prepare for upcoming fiscal and regulatory changes.

Takeaways

• Evaluating Mid-Year Financial Performance
• Identifying Denial Trends and Reimbursement Risks
• Improving Charge Capture and Revenue Integrity
• Assessing Underpayment Opportunities
• Measuring Prior Authorization Effectiveness
• Reviewing Aging Accounts Receivable
• * Preparing for the Second Half of the Fiscal Year

Chapters

00:00 Introduction: Why June Matters

01:33 Financial Performance Review

02:48 Denials Analysis

04:14 Charge Capture and Missing Revenue

06:13 Underpayment Analysis

07:39 Prior Authorization Performance

09:08 Aging Accounts Receivable

09:52 Finding Risk Before Year-End

11:02 Disclaimer

Disclaimer

This podcast is intended for informational and educational purposes only. The views expressed are personal opinions and do not represent those of any employer or affiliated organization. This content does not constitute legal, financial, compliance, reimbursement, or clinical advice. Healthcare regulations, payer policies, and reimbursement requirements vary by organization and jurisdiction. Always consult your internal compliance, legal, finance, revenue cycle, and operational teams before implementing any strategy discussed in this episode.

The podcast delves into the operational significance of the 835 remittance advice file in pharmacy revenue cycle management. It emphasizes the importance of understanding and leveraging the 835 file for reimbursement integrity, operational intelligence, and financial sustainability.

Takeaways

• Operational Significance of the 835 File
• Leveraging Remittance Data for Reimbursement Integrity

Chapters

• 00:00 835 Remittance Advice
• 01:47 Breaking Down the 835
• 05:46 Utilizing the 835 to Improve Performance

Disclaimer

This podcast is intended for informational and educational purposes only. The views expressed are personal opinions and do not represent those of any employer or affiliated organization. This content does not constitute legal, financial, compliance, reimbursement, or clinical advice. Healthcare regulations, payer policies, and reimbursement requirements vary by organization and jurisdiction. Always consult your internal compliance, legal, finance, revenue cycle, and operational teams before implementing any strategy discussed in this episode.

In this week's episode, we dive into the different claim pathways used to bill medications, including NCPDP D.0 for pharmacy benefits, 837P for professional claims, and 837I for institutional claims.

Takeaways

• Different claim pathways for medication billing
• Understanding the impact of claim pathways on reimbursement and operational workflows

Chapters

00:00 Introduction to Pharmacy Revenue Cycle Management

01:08 Pharmacy Benefit Claims: NCPDP D.0

04:05 Medical Benefit Claims: 837P

05:23 Medical Benefits Claim: 837I

06:10 Takeaway

08:08 Disclaimer

Disclaimer

This podcast is intended for informational and educational purposes only. The views expressed are personal opinions and do not represent those of any employer or affiliated organization. This content does not constitute legal, financial, reimbursement, compliance, or operational advice. Always consult your internal compliance, legal, finance, and revenue cycle teams before implementing any strategy discussed in this episode.

In this episode of Revenue Rx, we explore one of the most significant hidden threats in healthcare finance: pharmacy revenue leakage. The episode walks backward through the pharmacy revenue cycle, starting with reimbursement and denials management, then moving upstream into coding, charge capture, documentation, and prior authorizations.

The discussion highlights how reimbursement is connected to every handoff, workflow, click, and documentation requirement across the healthcare system. Small operational failures can create major downstream financial consequences, including denials, underpayments, compliance exposure, and permanent revenue loss.

Takeaways

• Revenue leakage is often caused by small operational breakdowns that compound across the revenue cycle.
• Denials management requires structured workflows, clear escalation pathways, and ongoing follow-up.
• Strong pharmacy revenue cycle management depends on cross-functional collaboration across clinical, financial, and operational teams.
• High-performing organizations use denials and reimbursement trends to improve workflows upstream.

Chapters

• 00:00 Introduction to Revenue Leakage
• 01:21 Reimbursement & Denials
• 04:16 Billing, Coding & Charge Integrity
• 05:52 Documentation & Medical Necessity
• 06:58 Prior Authorizations & Financial Risk
• 08:18 The Importance of Cross-Functional Collaboration
• 09:24 Disclaimer

Disclaimer

This podcast is intended for informational and educational purposes only. The views expressed are personal opinions and do not represent those of any employer or affiliated organization. This content does not constitute legal, financial, compliance, reimbursement, or clinical advice. Healthcare regulations, payer policies, and reimbursement requirements vary by organization and jurisdiction. Always consult your internal compliance, legal, finance, revenue cycle, and operational teams before implementing any strategy discussed in this episode.